06/30/2025 7:30 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2025 7:00 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2025 6:36 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2025 3:15 PM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2025 4:53 PM | BIOS Fund II, LP (Filed by) IN8bio (Subject)
| Form SCHEDULE 13D/A | |
05/07/2025 8:47 PM | Bios Equity Partners II, LP (Reporting) BIOS Equity Partners III, LP (Reporting) Bios Equity Partners, LP (Reporting) BIOS Fund III NT, LP (Reporting) BIOS Fund III QP, LP (Reporting) BIOS Fund III, LP (Reporting) BP Directors, LP (Reporting) Cavu Advisors, LLC (Reporting) Cavu Management, LP (Reporting) IN8bio (Issuer) Kreis Leslie W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 8:48 PM | BIOS Advisors GP, LLC (Reporting) BIOS Capital Management, LP (Reporting) Bios Clinical Opportunity Fund, LP (Reporting) Bios Equity COF, LP (Reporting) BIOS Fund II NT, LP (Reporting) BIOS Fund II QP, LP (Reporting) BIOS Fund II, LP (Reporting) BIOS Incysus Co-Invest I, LP (Reporting) Fletcher Aaron G.L. (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 7:45 PM | Brandt Peter C. (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 7:45 PM | IN8bio (Issuer) Roemer Alan S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 7:45 PM | IN8bio (Issuer) McCall Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 7:45 PM | IN8bio (Issuer) Rochlin Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for INAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter.
|
05/07/2025 7:45 PM | Ho William Tai-Wei (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 7:45 PM | Epperly Corinne (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 7:45 PM | Graff Jeremy R. (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 7:45 PM | IN8bio (Issuer) Lamb Lawrence (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2025 3:21 PM | IN8bio (Filer)
| Form 10-K/A | |
04/28/2025 7:56 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2025 7:56 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2025 4:02 PM | IN8bio (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/03/2025 8:29 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 3:41 PM | Ho William Tai-Wei (Filed by) IN8bio (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025 7:11 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2024 6:15 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/25/2024 6:09 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 11:15 PM | IN8bio (Filer)
| Form EFFECT | |
10/15/2024 3:04 PM | IN8bio (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/11/2024 5:12 PM | BIOS Advisors GP, LLC (Reporting) BIOS Capital Management, LP (Reporting) Bios Clinical Opportunity Fund, LP (Reporting) Bios Equity COF, LP (Reporting) BIOS Fund II NT, LP (Reporting) BIOS Fund II QP, LP (Reporting) BIOS Fund II, LP (Reporting) BIOS Incysus Co-Invest I, LP (Reporting) Fletcher Aaron G.L. (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2024 5:13 PM | Bios Equity Partners II, LP (Reporting) BIOS Equity Partners III, LP (Reporting) Bios Equity Partners, LP (Reporting) BIOS Fund III NT, LP (Reporting) BIOS Fund III QP, LP (Reporting) BIOS Fund III, LP (Reporting) BP Directors, LP (Reporting) Cavu Advisors, LLC (Reporting) Cavu Management, LP (Reporting) IN8bio (Issuer) Kreis Leslie W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2024 5:01 PM | BIOS Fund II, LP (Filed by) IN8bio (Subject)
| Form SC 13D/A | |
10/09/2024 4:19 PM | HIRSCHMAN ORIN (Filed by) IN8bio (Subject)
| Form SC 13G | |
10/08/2024 3:15 PM | Ho William Tai-Wei (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:15 PM | Brandt Peter C. (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:15 PM | IN8bio (Issuer) Roemer Alan S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:15 PM | IN8bio (Issuer) McCall Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:15 PM | IN8bio (Issuer) Rochlin Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:15 PM | FAIRBAIRN EMILY (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 6:30 PM | HIRSCHMAN ORIN (Filed by) IN8bio (Subject)
| Form SC 13G/A | |
09/11/2024 3:01 PM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 3:35 PM | IN8bio (Issuer) McCall Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:35 PM | IN8bio (Issuer) Rochlin Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:35 PM | Goswami Trishna (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Private Market Surge Is Coming in 2025 (Ad) The most lucrative investment opportunities are reserved for a select category of investor.
They're private. They're quiet. And they're often available exclusively to accredited investors operating outside the noise of the public markets.
We're talking about off-market placements, early venture deals, private credit, and pre-IPO shares—the kind of plays that can generate outsized gains before Wall Street catches wind.
Here's the reality: having access is only the beginning. These deals can be opaque, rushed, and filled with hidden risk. That's why we created something exclusively for investors like you—the 2025 Accredited Investor Playbook. Get your copy now: [Access the 2025 Accredited Investor Playbook] |
09/05/2024 3:35 PM | Ho William Tai-Wei (Reporting) IN8bio (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:35 PM | IN8bio (Issuer) Lamb Lawrence (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 3:18 PM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 4:11 PM | IN8bio (Filer)
| Form 424B5 | |
08/12/2024 7:30 AM | IN8bio (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |